{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:14Z","timestamp":1795026734667,"version":"4.10.2"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To evaluate arterial fluorodeoxyglucose (FDG) uptake as a marker of arterial inflammation in multiple vascular beds in patients treated with anthracycline-based chemotherapy for Hodgkin lymphoma (HL).<\/jats:p>\n            <jats:p>We used maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) to quantify arterial FDG uptake in the carotid artery, ascending aorta, abdominal aorta, and femoral artery obtained on positron emission tomography\/computed tomography (PET\/CT) imaging performed at baseline before chemotherapy and after completion of chemotherapy in patients with HL treated with an anthracycline-containing regimen. We compared the SUVmax and TBR obtained at baseline with that obtained post-chemotherapy for each arterial bed to evaluate the effect of anthracycline-based chemotherapy. We evaluated the effect of cardiovascular risk factors such as human immunodeficiency virus (HIV) infection, smoking, hypertension, and diabetes on the changes in SUVmax and TBR seen in the different arterial beds after anthracycline-based chemotherapy.<\/jats:p>\n            <jats:p>Fifty-two patients were included with a mean age of 34.56\u200a\u00b1\u200a10.19 years. There were 33 males, and 18 patients were HIV-infected. The mean interval between completion of chemotherapy and follow-up flourine-18 fluorodeoxyglucose positron emission tomography\/computed tomography (FDG PET\/CT) scan was 65 weeks. We found no significant difference in arterial FDG uptake measured by SUVmax and TBR in all arterial beds between the pre- and post-chemotherapy FDG PET\/CT. There was no significant impact of HIV infection, smoking, and hypertension on the changes in arterial FDG uptake following treatment with anthracycline-based chemotherapy.<\/jats:p>\n            <jats:p>In patients with HL who were treated with anthracycline-based chemotherapy, we found no significant increase in arterial inflammation measured by FDG PET\/CT after an average follow-up period of about 65 weeks since completion of chemotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023259","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T19:06:22Z","timestamp":1606158382000},"page":"e23259","source":"Crossref","is-referenced-by-count":9,"title":["FDG PET\/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma"],"prefix":"10.1097","volume":"99","author":[{"given":"Ismaheel O.","family":"Lawal","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"},{"name":"Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akintunde T.","family":"Orunmuyi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Ibadan, Ibadan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga O.","family":"Popoola","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabo","family":"Lengana","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"},{"name":"KVNR Nuclear and Molecular Imaging, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kgomotso M.G.","family":"Mokoala","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred O.","family":"Ankrah","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"},{"name":"Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"},{"name":"Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"R1-20240523","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1111961","article-title":"ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma","volume":"366","author":"Meyer","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-20240523","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.radonc.2018.06.033","article-title":"Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy","volume":"129","author":"Moding","year":"2018","journal-title":"Radiother Oncol"},{"key":"R4-20240523","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"R5-20240523","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cam4.1914","article-title":"Dysfunctional endothelial progenitor cells in patients with Hodgkin's lymphoma in complete remission","volume":"8","author":"Wiessman","year":"2019","journal-title":"Cancer Med"},{"key":"R6-20240523","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-20240523","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegan","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R8-20240523","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cjca.2012.06.023","article-title":"The biological role of inflammation in atherosclerosis","volume":"28","author":"Wong","year":"2012","journal-title":"Can J Cardiol"},{"key":"R9-20240523","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"R10-20240523","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"R11-20240523","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R12-20240523","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejvs.2008.11.018","article-title":"Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET)","volume":"37","author":"Graebe","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R13-20240523","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCIMAGING.113.000382","article-title":"Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET\/CT study","volume":"6","author":"Abdelbaky","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"R14-20240523","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","article-title":"18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease","volume":"50","author":"Rominger","year":"2009","journal-title":"J Nucl Med"},{"key":"R15-20240523","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s12350-018-1207-x","article-title":"Arterial inflammation in young patients with human immunodeficiency virus infection: a cross-sectional study using F-18 FDG PET\/CT","volume":"26","author":"Lawal","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R16-20240523","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jcmg.2013.08.006","article-title":"Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV event","volume":"6","author":"Figueroa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"R17-20240523","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00259-017-3766-5","article-title":"The role of F-18 FDG PET\/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma","volume":"44","author":"Lawal","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20240523","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-013-2686-2","article-title":"Current role of FDG PET\/CT in lymphoma","volume":"41","author":"Kostakoglu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-20240523","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3413\/Nukmed-0864-16-11","article-title":"18F-FDG PET\/CT in the detection of asymptomatic malignant melanoma recurrence","volume":"56","author":"Lawal","year":"2017","journal-title":"Nuklearmedizin"},{"key":"R20-20240523","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"45","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-20240523","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00259-015-3259-3","article-title":"Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis","volume":"43","author":"Bucerius","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R22-20240523","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta","year":"2016","journal-title":"Lancet Oncol"},{"key":"R23-20240523","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"R24-20240523","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00259-015-3203-6","article-title":"Increased arterial inflammation in individuals with stage 3 chronic kidney disease","volume":"43","author":"Takx","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-20240523","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00259-016-3524-0","article-title":"Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression","volume":"44","author":"Joseph","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-20240523","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2009.23.8527","article-title":"Aortic stiffness increases upon receipt of anthracycline chemotherapy","volume":"28","author":"Chaosuwannakit","year":"2010","journal-title":"J Clin Oncol"},{"key":"R27-20240523","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"R28-20240523","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12253-012-9589-6","article-title":"Anthracycline causes impaired vascular endothelial fumction and aortic stiffness in long term survivors of childhood cancer","volume":"19","author":"Jenei","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"R29-20240523","first-page":"191","article-title":"Effects of anthracyclines on aortic distensibility in patients with lymphomas: a prospective study","volume":"55","author":"Daskalaki","year":"2014","journal-title":"Hellenic J Cardiol"},{"key":"R30-20240523","doi-asserted-by":"crossref","first-page":"dju110","DOI":"10.1093\/jnci\/dju110","article-title":"Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943\u20132009","volume":"106","author":"Rugbjerg","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R31-20240523","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41824-019-0053-7","article-title":"Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective","volume":"3","author":"Lawal","year":"2019","journal-title":"Eur J Hybrid Imaging"},{"key":"R32-20240523","article-title":"Impact of optimized PET imaging conditions on 18F-FDG uptake quantification in patients with apparently normal aortas","author":"Lawal","year":"2019","journal-title":"J Nucl Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:17:33Z","timestamp":1716473853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023259"}},"subtitle":["A retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":31,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023259","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}